Remove ACE Inhibitor Remove Heart attacks Remove Outcomes
article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. Researchers tracked outcomes for a median of just under 18 months. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries.

article thumbnail

What Should Your Blood Pressure Be?

Dr. Paddy Barrett

The answer is pretty simple, but most people get this wrong, and doing so increases their future risk of heart attack and strokes. Most people with high blood pressure will be treated with an ACE inhibitor, ARB, calcium channel blocker or a diuretic. Outcome over process, in my view, works best here. Hypertension.

article thumbnail

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

article thumbnail

What is wrong with the NHS? Part two.

Dr. Malcolm Kendrick

20th October 2023 (With lessons from, and for, all other health services around the world) The Quality and Outcomes Framework The Quality and Outcomes Framework (QOF) was to be the glittering triumph of Evidence Based Medicine. The aim is to reduce death and damage from nasty things such as heart attacks and strokes.